What does Poppins do?
Poppins is a Paris-based neurotech startup focused on developing medical devices and digital solutions to support the treatment of neurodevelopmental disorders, with a particular emphasis on dyslexia. Its innovative video game app leverages rhythmic and auditory stimuli to complement traditional speech therapy.
How much did they raise?
The company raised €5M in a funding round that was led by Racine, with participation from Bpifrance Patient Autonome fund, Eurazeo, Kurma Partners, BNP Paribas Développement, and Verve Ventures.
What are their plans for the money?
The funds will be used to expand Poppins' operations and intensify its development efforts, potentially broadening the impact of its home-based therapeutic solutions for individuals with neurodevelopmental challenges.
What have they achieved so far?
Since its founding in 2018 by François Vonthron and Antoine Yuen from École Polytechnique, Poppins has successfully developed an innovative video game app that enhances speech therapy care for dyslexia.
